Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Qian

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[Multiple myeloma cell line U266 apoptosis induced by velcade]Li-Juan Chen, Jian-Yong Li, Si-Xuan Qian, et al.
Science Bulletin|January 20, 2023
Coherent rainbows from solidsTian-Jiao Sun, Xuan Qian, Ya-Xuan Shang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[High-dose methylprednisolone for the treatment of refractory chronic lymphocytic leukemia]Ming Hong, Wei Xu, Si-Xuan Qian, et al.
Leukemia & Lymphoma|May 9, 2008
Acute myeloid leukemia in four patients with t(8;21) treated with all-trans retinoic acid as a single agentSi-Xuan Qian, Jian-yong Li, Min Hong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 5, 2008
[Tandem double autologous peripheral blood stem cell transplants for de novo multiple myeloma]Run Zhang, Jian-Yong Li, Hua Lu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2022
[The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia]Lu Liu, Xiao Chen, Hui-Min Jin, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 22, 2009
[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia]Si-Xuan Qian, Jian-Yong Li, Han-Xin Wu, et al.
Haematologica|July 13, 2014
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patientsChun Qiao, Chao Sun, Yuan Ouyang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 30, 2014
[Nilotinib treatment for patients with imatinib-resistant or intolerant chronic myeloid leukemia]Liang-Qin Pan, Wei-Xin Liu, Yu Zhu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Distribution of Natural Killer Cell in Patients with Newly Diagnosed Myelodysplastic Syndromes and Its Correlation with Prognosis]Shan Li, Ming Hong, Jing-Jing Zhang, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[Multiple myeloma cell line U266 apoptosis induced by velcade]Li-Juan Chen, Jian-Yong Li, Si-Xuan Qian, et al.
Science Bulletin|January 20, 2023
Coherent rainbows from solidsTian-Jiao Sun, Xuan Qian, Ya-Xuan Shang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[High-dose methylprednisolone for the treatment of refractory chronic lymphocytic leukemia]Ming Hong, Wei Xu, Si-Xuan Qian, et al.
Leukemia & Lymphoma|May 9, 2008
Acute myeloid leukemia in four patients with t(8;21) treated with all-trans retinoic acid as a single agentSi-Xuan Qian, Jian-yong Li, Min Hong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 5, 2008
[Tandem double autologous peripheral blood stem cell transplants for de novo multiple myeloma]Run Zhang, Jian-Yong Li, Hua Lu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2022
[The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia]Lu Liu, Xiao Chen, Hui-Min Jin, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 22, 2009
[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia]Si-Xuan Qian, Jian-Yong Li, Han-Xin Wu, et al.
Haematologica|July 13, 2014
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patientsChun Qiao, Chao Sun, Yuan Ouyang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 30, 2014
[Nilotinib treatment for patients with imatinib-resistant or intolerant chronic myeloid leukemia]Liang-Qin Pan, Wei-Xin Liu, Yu Zhu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Distribution of Natural Killer Cell in Patients with Newly Diagnosed Myelodysplastic Syndromes and Its Correlation with Prognosis]Shan Li, Ming Hong, Jing-Jing Zhang, et al.
Pageof 13